Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya

Table 1 List of primary antibodies

Antibody	Vendor/clone	Pretreatment	Dilution	Control tissue	Detection/linker	Incubation time (minutes)
ER	Dako IR084	TRS high pH	RTU	Breast Ca	Flex	20/20/10
PR	DakoIR068	TRS low pH	RTU	Breast Ca	Flex + M	20/20/20/10
HER2	Dako SK001	Herceptest antigen retrieval		Herceptest	Herceptest	30/30/10
Ki-67	DakoIR626	TRS high pH	RTU	Breast	Flex	20/20/10
CD4	DakoIR649	TRS high pH	RTU	Tonsil	Flex + M	15/10/10/10
CD8	DakoIR623	TRS low pH	RTU	Tonsil	Flex + M	15/15/15/10
CD68KPI	DakoIR609	TRS high pH	RTU	Tonsil	Flex	20/10/10
CD20	DakoIR604	TRS high pH	RTU	Tonsil	Flex	10/10/10
CD25	NC NCLCD25-305	TRS high pH	1:100	Tonsil	Flex + M	15/10/10/10
CD163	Vector Laboratories Inc.VP6017007	TRS high pH	1:100	Bone Marrow	Flex + M	15/10/10/10

ISSN: 1349-4147